Surgery

With more than 10,000 providers from around the world converging on the American Heart Association's Scientific Sessions, lessons from the event can be implemented as soon as the next day or show promise of work to come in the future.

The treatment of cardiovascular disease for men may be ahead of where it is for women, but there is a concerted effort to bring the two into a more balanced measure.

A lot is yet to be determined about the potential benefits of precision medicine in cardiology. As that field develops, there will also be questions about the varying benefits for men and women.

Praluent has been studied at a variety of levels and, now that it's been approved, there has been more insight on its benefits and risks.

With statins being a common treatment option to help patients reduce their cholesterol levels, the still relatively newly approved PCSK9 inhibitors have proven a valuable tool. However, they are not enough to help eliminate concerns about cardiac care and cholesterol.

Doctors prescribing Praluent for their patients have two dosing options to choose from. Studies on the treatment option have shown that the safety profile for both are good for patients.

In just over a year, Praluent has shown benefits in helping patients lower their cholesterol level. Despite the progress, there have also been some challenges.

For doctors concerned about cardiovascular disease in patients, there have been some lingering questions about the best medications to prescribe.

A study comparing whether certain heart patients did better with bilateral arterial grafts than single grafts had the surprising result of finding no benefit at five years.

Researchers have proposed three key risk factors for transmission and acquisition of carbapenemase-producing carbapenem-resistant Enterobacteriaceae.

The search for newer antimicrobial agents is a focus of those looking to help prevent patients from developing potentially dangerous conditions while admitted to the hospital.

In many hospitals there is a consistent effort to monitor how patients are responding to various treatments. This can be done at different increments which can determine in some cases how effective treatments are against pathogens which can affect a patients' health.

There are more and more challenges facing patients and doctors in hospital settings as "superbugs," or those conditions which are resistant to medications and antibiotics become a greater problem.

Do physicians feel voting is a waste of time? They are less likely to go to the polls than the average person, and far less likely to cast ballots than lawyers.

For conditions like diabetic retinopathy, the earlier the condition diagnosis can be made, the better the odds are of reducing the damage done.

In many, if not most cases, there can be a break in the chain between researchers and the doctors they are developing treatments for. When that divide does not exist it can mean more direct access for doctors and patients to the latest treatments even in the development stages.

There are hundreds of thousands of people in the United States with medication-resistant epilepsy. For many, their condition could be better managed by learning more about it and finding the right specialist who can help.

There are currently close to three million people in the United States with epilepsy. Of that total, close 500,000 are classified as medication resistant. Work is underway to help bring that number down and help more people with the condition.

In some patients, treating uveitis or glaucoma can be difficult enough when patients have both conditions simultaneously it can complicate the treatment process that much more.

Much in the way GPS systems help drivers navigate the roads easier, image guided surgery can help doctors provide better care to their patients in many cases.

On a daily basis endocrinologists are treating a wide variety of conditions that require their own specifics of care. Because of that there is an increased need for not only more specialists in the field, but also for general practitioners to provide care for more controlled patients.

For many people with thyroid issues a medication can help them better manage their condition. For 10 percent there are lingering problems that need to be addressed.

As more is learned about thyroid diseases in endocrinology one of the questions looming now is why does the thyroid hormone affect the body the way that it does. There are also questions about whether some health conditions are really tied to the hormone or another part of the anatomy.

The treatment of wet age-related macular degeneration has come a long way in a short period of time. While it may take some explaining that injections in the eye are the best way to treat the condition now there is work being done to find better ways for the future.

If patients with the wet form of wet age-related macular degeneration are caught early enough there are treatments available to help treat the condition.

Space flight has changed dramatically from the days of the Mercury and Apollo programs. With an eye towards Mars research is being done to see what impact long-term flights will have on a person's body.

The treatment of pediatric glaucoma can be successful if caught early, and sometimes that can mean a surgical procedure on the day of the first visit to a specialist.

Only one in 10,000 children will be diagnosed with pediatric glaucoma. If the condition is caught soon enough, surgical options can help treat the condition and give the patients a regular quality of life for their future.

There are many challenges that confront pain specialists on a daily basis. Despite those challenges, seeing their patients recover and live a better quality of life is reward enough to keep them optimistic for the future of the field.

Injectable medications are being used for everything from chronic pain to cancer related pain. While doctors are working to help their patients manage their symptoms they are also keeping a close eye on potential abuse and illegal activity with the medication.